Sandostatin LAR in acromegaly: a 6-week injection interval suppresses GH secretion as effectively as a 4-week interval.
第一作者:
Nienke R,Biermasz
第一单位:
Department of Metabolism and Endocrinology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, the Netherlands. n.r.biermasz@lumc.nl
作者:
主题词
肢端肥大症(Acromegaly);成年人(Adult);老年人(Aged);迟效制剂(Delayed-Action Preparations);抑制, 化学性(Depression, Chemical);用药计划表(Drug Administration Schedule);女(雌)性(Female);激素类(Hormones);人类(Humans);注射(Injections);胰岛素样生长因子Ⅰ(Insulin-Like Growth Factor I);男(雄)性(Male);中年人(Middle Aged);奥曲肽(Octreotide);前瞻性研究(Prospective Studies);生长抑素(Somatostatin)
DOI
10.1046/j.1365-2265.2003.01710.x
PMID
12608933
发布时间
2019-12-10
- 浏览10

Clinical endocrinology
288-95页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文